HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-137 Cr | ₹-174 Cr | ₹-292 Cr | ₹-284 Cr | ₹-156 Cr |
What is the latest Cash Flow from Investing Activities ratio of HIKAL ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-137 Cr |
| Mar2024 | ₹-174 Cr |
| Mar2023 | ₹-292 Cr |
| Mar2022 | ₹-284 Cr |
| Mar2021 | ₹-156 Cr |
How is Cash Flow from Investing Activities of HIKAL Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-137 Cr | Negative | |
| Mar2024 | ₹-174 Cr | Negative | |
| Mar2023 | ₹-292 Cr | Negative | |
| Mar2022 | ₹-284 Cr | Negative | |
| Mar2021 | ₹-156 Cr | - | |
Compare Cash Flow from Investing Activities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,489.4 Cr | -5.3% | 12.5% | -47.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -5.3% |
12.5% |
-47.8% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses